Flexi-Cap protects against counterfeit drugs

Schreiner MediPharm presents new security concept for original containers at CPhI Worldwide 2014

The solution is usable with different container types, forms and sizes

An innovative security solution that combines first-opening indication and labelling will be introduced by Schreiner MediPharm at this year's InnoPack on Stand 2J40, as part of the CPhI Worldwide trade fair in Paris from 7-9 October 2014. Flexi-Cap irreversibly shows that a primary container has been opened, and thus prevents illegal reuse and filling of empty containers with counterfeit substances.

The new security concept from Schreiner MediPharm is based on an innovative combination of label and cap and prevents the problem of empty original containers being taken from the waste stream, refilled and sold illegally as originals.

The film cap is first put over the closed container, then the label is applied without covering the peel-open tab on the opening strip. Once the strip is opened, the bottom part of the cap, together with the label, remains attached to the container. Attempting to remove the rest of the cap destroys the label. This eliminates the possibility of illegal, unnoticed reuse.

The solution is usable with different container types, forms and sizes. Unlike shrink-wrap solutions, the label construction can be applied without using heat, making it suitable for temperature-sensitive medicines. The top of Flexi-Cap allows space for bar code printing or NFC chip integration for electronic tracking.

In addition, important user information can be communicated and patient compliance documented. The multilayer label provides enough space for information in several languages. Administration can be documented easily with the integration of detachable label parts. Robust hangers can also be included.

Adding extra security features such as holographs, colour-shifting inks, guilloches or hidden features such as a void effects or LaserSecure pigments gives suppliers, pharmacists, medical personnel and patients additional certainty that the product is genuine.

Companies